Covered recipient · General Payments record
LUPE YEPEZ-MICHEL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$5,881.67
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,552.35 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $470.10 | 5 |
| Acerta Pharma LLC | $214.89 | 2 |
| ABBVIE INC. | $210.89 | 2 |
| Abbott Laboratories | $132.56 | 1 |
| GlaxoSmithKline, LLC. | $125.00 | 1 |
| Verrica Pharmaceuticals Inc. | $95.24 | 1 |
| ACADIA Pharmaceuticals Inc | $94.84 | 1 |
| Hologic Sales and Service, LLC | $93.20 | 1 |
| PFIZER INC. | $79.43 | 1 |
| OptiNose US, Inc. | $22.92 | 1 |
| Lilly USA, LLC | $13.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $132.56 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125354445 | CMS |
| ABBVIE INC. | $85.89 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449169 | CMS |
| ABBVIE INC. | $125.00 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449171 | CMS |
| ACADIA Pharmaceuticals Inc | $94.84 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148016624 | CMS |
| Amgen Inc. | $87.45 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117723630 | CMS |
| Amgen Inc. | $123.72 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117420460 | CMS |
| Amgen Inc. | $124.77 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117420456 | CMS |
| Amgen Inc. | $16.39 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117420458 | CMS |
| Amgen Inc. | $117.77 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117723632 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105512691 | CMS |
| AstraZeneca Pharmaceuticals LP | $89.89 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105409599 | CMS |
| GlaxoSmithKline, LLC. | $125.00 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116153051 | CMS |
| Hologic Sales and Service, LLC | $93.20 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084905376 | CMS |
| Lilly USA, LLC | $13.28 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135827375 | CMS |
| Optinose US, Inc. | $22.92 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142192335 | CMS |
| PFIZER INC. | $79.43 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131797268 | CMS |
| Verrica Pharmaceuticals Inc. | $95.24 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118398808 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.